Results
|
5021.
|
|
|
5022.
|
Pulmonary toxicity in patients receiving docetaxel chemotherapy. [electronic resource] by
- Yumuk, Perran F
- Kefeli, Umut
- Ceyhan, Berrin
- Dane, Faysal
- Eroglu, Basak T
- Gumus, Mahmut
- Cabuk, Devrim
- Basaran, Gul
- Abacioglu, Ufuk
- Turhal, Nazım S
Producer: 20110408
In:
Medical oncology (Northwood, London, England) vol. 27
Availability: No items available.
|
|
5023.
|
|
|
5024.
|
A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. [electronic resource] by
- Moulder, Stacy
- Gladish, Gregory
- Ensor, Joe
- Gonzalez-Angulo, Ana Maria
- Cristofanilli, Massimo
- Murray, James L
- Booser, Daniel
- Giordano, Sharon H
- Brewster, Abeena
- Moore, Julia
- Rivera, Edgardo
- Hortobagyi, Gabriel N
- Tran, Hai T
Producer: 20120612
In:
Cancer vol. 118
Availability: No items available.
|
|
5025.
|
|
|
5026.
|
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognoses. [electronic resource] by
- Campbell, H E
- Epstein, D
- Bloomfield, D
- Griffin, S
- Manca, A
- Yarnold, J
- Bliss, J
- Johnson, L
- Earl, H
- Poole, C
- Hiller, L
- Dunn, J
- Hopwood, P
- Barrett-Lee, P
- Ellis, P
- Cameron, D
- Harris, A L
- Gray, A M
- Sculpher, M J
Producer: 20120103
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
5027.
|
|
|
5028.
|
|
|
5029.
|
|
|
5030.
|
|
|
5031.
|
|
|
5032.
|
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study. [electronic resource] by
- Petrioli, R
- Pascucci, A
- Conca, R
- Chiriacò, G
- Francini, E
- Bargagli, G
- Fiaschi, A I
- Manganelli, A
- De Rubertis, G
- Barbanti, G
- Ponchietti, R
- Francini, G
Producer: 20110502
In:
British journal of cancer vol. 104
Availability: No items available.
|
|
5033.
|
|
|
5034.
|
|
|
5035.
|
|
|
5036.
|
|
|
5037.
|
|
|
5038.
|
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. [electronic resource] by
- Jimeno, Antonio
- Bauman, Julie E
- Weissman, Charles
- Adkins, Douglas
- Schnadig, Ian
- Beauregard, Patrice
- Bowles, Daniel W
- Spira, Alexander
- Levy, Benjamin
- Seetharamu, Nagashree
- Hausman, Diana
- Walker, Luke
- Rudin, Charles M
- Shirai, Keisuke
Producer: 20151207
In:
Oral oncology vol. 51
Availability: No items available.
|
|
5039.
|
|
|
5040.
|
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. [electronic resource] by
- Wang, Jinwan
- Xu, Ruihua
- Li, Jian
- Bai, Yuxian
- Liu, Tianshu
- Jiao, Shunchang
- Dai, Guanghai
- Xu, Jianming
- Liu, Yunpeng
- Fan, Nanfeng
- Shu, Yongqian
- Ba, Yi
- Ma, Dong
- Qin, Shukui
- Zheng, Leizhen
- Chen, Weichang
- Shen, Lin
Producer: 20170110
In:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 19
Availability: No items available.
|